{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:54:01Z","timestamp":1791176041956,"version":"4.1.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Musclin is a skeletal muscle-derived myokine with reported cardioprotective effects; however, its prognostic relevance in acute aortic dissection (AAD) remains uncertain. This study examined whether admission Musclin levels were associated with postoperative major adverse cardiovascular events (MACE) and whether they added prognostic information beyond conventional clinical indicators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively enrolled 108 surgically treated AAD patients from 2022 to 2023. Musclin levels were measured by ELISA in residual serum samples collected at admission. The primary endpoint was composite MACE. Kaplan\u2013Meier survival analysis, multivariate Cox regression, time-dependent ROC, IDI and NRI were used to evaluate the predictive and incremental value of Musclin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During 400-day follow-up, 36 patients (33.3%) developed MACE. The CART-derived optimal Musclin cutoff was 4.815\u2005ng\/mL. Kaplan\u2013Meier analysis showed that low Musclin group had significantly higher MACE cumulative incidence than high Musclin group (48.2% vs. 17.3%, log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Multivariate Cox regression confirmed circulating Musclin associated with a lower risk of MACE (HR\u2009=\u20090.314, 95%CI: 0.104\u20130.943,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.039). Time-dependent AUC analysis demonstrated that the combined model incorporating Musclin (model 2) achieved superior AUC compared with the clinical model (model 1). Even at the 250-day time point, where the incremental gain (\n                      <jats:italic>\u0394<\/jats:italic>\n                      AUC) was minimal, the combined model still exhibited significantly better discriminative performance (0.876 vs. 0.837, DeLong\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.013). At the 250-day landmark, IDI was 0.153 (95%CI: 0.018\u20130.286,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012) and overall NRI was 0.167 (95%CI: 0.003\u20130.336,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.044), with event-specific NRI reaching 0.361 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.012). Sensitivity analyses yielded directionally consistent associations when Musclin was analyzed using the cohort median or as a continuous variable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this single-center retrospective cohort, lower admission Musclin was associated with a higher risk of postoperative MACE. Musclin may be a severity-related biomarker that could complement conventional risk indicators, but its independent clinical utility, optimal threshold, and role in risk stratification require prospective multicenter validation with comprehensive perioperative adjustment before clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1953235","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:33:55Z","timestamp":1791174835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating musclin as a potential prognostic biomarker for major adverse cardiovascular events in surgically treated acute aortic dissection: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Nursing, Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Wu","sequence":"additional","affiliation":[{"name":"Endoscopy Center, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huining","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Hospital of Hebei Medical University","place":["Shijiazhuang, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14017431.2019.1660401","article-title":"Acute type A aortic dissection - a review","volume":"54","author":"Gudbjartsson","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jacc.2015.05.029","article-title":"Presentation, diagnosis, and\u00a0outcomes of\u00a0acute aortic dissection","volume":"66","author":"Pape","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e012350","DOI":"10.1161\/CIRCHEARTFAILURE.124.012350","article-title":"Musclin counteracts skeletal muscle dysfunction and exercise intolerance in heart failure with preserved ejection fraction","volume":"18","author":"Saw","year":"2025","journal-title":"Circ Heart Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19391","DOI":"10.1074\/jbc.C400066200","article-title":"Musclin, a novel skeletal muscle-derived secretory factor","volume":"279","author":"Nishizawa","year":"2004","journal-title":"J Biol Chem"},{"key":"B5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41467-021-27634-5","article-title":"Skeletal muscle derived musclin protects the heart during pathological overload","volume":"13","author":"Szaroszyk","year":"2022","journal-title":"Nat Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"745328","DOI":"10.3389\/fphys.2021.745328","article-title":"Remote hind-limb ischemia mechanism of preserved ejection fraction during heart failure","volume":"12","author":"Homme","year":"2021","journal-title":"Front Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11886-022-01642-3","article-title":"Diagnosis and management of acute aortic syndromes: dissection, penetrating aortic ulcer, and intramural hematoma","volume":"24","author":"Sorber","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.21037\/atm-20-3259","article-title":"Decreased plasma musclin levels are associated with potential atrial fibrillation in non-diabetic patients","volume":"9","author":"Zhong","year":"2021","journal-title":"Ann Transl Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/medsci14020177","article-title":"Sarcopenia as a prognostic marker of early mortality after surgery for acute aortic dissection: a prospective cohort study","volume":"14","author":"Sema\u0144","year":"2026","journal-title":"Med Sci (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/JOE-08-0551","article-title":"Competitive binding of musclin to natriuretic peptide receptor 3 with atrial natriuretic peptide","volume":"201","author":"Kita","year":"2009","journal-title":"J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1161\/CIRCRESAHA.117.312624","article-title":"A new secretory peptide of natriuretic peptide family, osteocrin, suppresses the progression of congestive heart failure after myocardial infarction","volume":"122","author":"Miyazaki","year":"2018","journal-title":"Circ Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13697","DOI":"10.1111\/eci.13697","article-title":"The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections","volume":"52","author":"Rombouts","year":"2022","journal-title":"Eur J Clin Investig"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.21037\/jtd-24-196","article-title":"Clinical usefulness of psoas muscle thickness for the prognosis of acute type A aortic dissection patients undergoing total arch replacement","volume":"16","author":"Lin","year":"2024","journal-title":"J Thorac Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.3390\/jcm12175573","article-title":"Sarcopenia adversely affects outcomes following cardiac surgery: a systematic review and meta-analysis","volume":"12","author":"Ansaripour","year":"2023","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3390\/medicina61091551","article-title":"The role of biomarkers and clinical prediction tools in the diagnosis of acute aortic syndromes: a literature-based review","volume":"61","author":"Pignataro","year":"2025","journal-title":"Medicina (B Aires)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.amjcard.2023.11.053","article-title":"Biomarkers for risk stratification in patients with type A acute aortic dissection","volume":"212","author":"Yamamoto","year":"2024","journal-title":"Am J Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models","volume":"176","author":"Pencina","year":"2012","journal-title":"Am J Epidemiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1953235\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:34:09Z","timestamp":1791174849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1953235\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2026.1953235"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1953235","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1953235"}}